SUMMARY. SVe consider identifying the minimum effective dose (LIED) in a dose-response study, where the MED is defined to be the lowest dose level producing an effect over that of the zero-dose control. Proposed herein is a nonparametric procedure based on the Mann-Whitney statistic incorporated with the step-down closed testing scheme. A numerical example demonstrates the feasibility of the proposed nonparametric procedure. Finally, the comparative results of a Llonte Carlo level and pourer study for small sample sizes are presented and discussed.
Introduction
In toxicological and drug development studies, several increasing dose levels of a substance are usually compared with the zero-dose control to investigate the effect of the substance. For this purpose, a dose-response experiment is often conducted in a one-way layout in which the doses of the substance under consideration are administered to separate groups of subjects. There are different concerns in these studies. In toxicological studies, the major concern is the safety of the toxin under consideration. Therefore, the goal is to estimate the highest dose that s h o~~s no significant difference from the zero-dose control, which is generally called the no statistical significance of trend (NOSTASOT; Tukey, Ciminera, and Heyse, 1985) or no observed adverse event level (NOAEL; Ryan, 1992) dose. In drug development studies, however, the primary interest is identifying the lowest dose level producing a desirable effect over that of the zero-dose control, which is commonly referred as the minimum effective dose (MED; Ruberg, 1989) .
The conventional approach in toxicological studies is to identify the NOSTASOT or NOAEL dose and apply appropriate safety factors to it to reach a safe dose level. Since this approach tends to overestimate the safe dose level in smaller and less sensitive experiments, an alternative approach based on estimation of the benchmark dose (Crump, 1984 ) from a suitable dose-response model seems to be more preferable in recent years. The alternative approach involves fitting data with a dose-response curve and estimating the dose level corresponding to a specified risk level (e.g., EDol, which causes a 1% increase in risk over the zero-dose control). Based on the upper confidence limit on the risk level at the estimated EDol, a safety factor is obtained to arrive at the safe dose level.
The regression-based quantitative approach is not commonly used in drug development studies since it is impractical to specify such an amount of increase in effect over the zero-dose control so that the corresponding dose level causes a desirable effect. LIoreover, no extrapolation from the experimental data is involved. Therefore, this paper mainly discusses a test-based approach to identifying the NED in drug development studies. Note that, in these drug studies, increasing dose levels are frequently expected to produce stronger or at least equal treatment effects. However, it also happens often that, due to the toxic effects at high doses, an ordering in the treatment effects is anticipated that is monotonically increasing up to a point, followed by a monotonic decrease. Since this corresponds to an up-down ordering of the treatment effects, they are said to follo15-an umbrella pattern. The point that separates the treatment effects into the two different ordering groups is called the peak of the umbrella (Vlack and Wolfe, 1981) .
The problem of identifying the MED has been investigated by several authors for normally distributed responses with a common variance. For example, Williams (1971) considered a closed testing procedure based on the isotonic regression of the sample means for a monotonic dose-response relationship. Ruberg (1989) suggested tests based on different contrasts of sample means to identify the VlED. Tamhane, Hochberg, and Dunnett (1996) further proposed contrast-based closed testing procedures for identifying the VIED. In dose-response studies, however, it occurs frequently that the normal assumption is not tenable or the observatio~ls are too few to rely on the central limit theorem for normality. In these cases, nonparametric procedures providing practical alternatives for identifying the MED are then needed. For example, Shirley (1977) considered a nonparalnetric equivalent of Williams' (1971) test for contrasting increasing dose levels. Williams (1986) further suggested a modification of Shirley's (1977) test. Chen and SVolfe (1993) proposed nonparametric procedures for comparing umbrella pattern treatment effects with a control for cases both when the peak of the umbrella is known or unknown. LIoreover, Chen (1993) suggested a modified Chen-Wolfe test for peak-known umbrella setting. In fact, the modified Chen-Wolfe test is identical to Williams' (1986) closed test when treatment effects are monotonically ordered. However, all of these nonparametric procedures are based on the isotonic regressions of the average ranks under appropriate order restrictions, which need quite a lot of computational effort. Therefore, we consider in this paper employing the step-down closed testing scheme suggested by Tamhane et al. (1996) , but we utilize the Vlann-Whitney (Vlann and Whitney, 1947) statistic for identifying the NED.
In Section 2, we propose a nonparametric closed testing procedure to identify the NED. In Section 3, the use of the proposed procedures is demonstrated with the numerical example involving Ames salmonella/microsome test data previously analyzed in Chen and Wolfe (1993) . Section 4 presents the comparative results of a Monte Carlo study investigation of the relative level and pourer performances of several competing procedures for a variety of patterns of treatment effects configurations. The final section contains some conclusions.
The Proposed Testing Procedure
For the ith sample (i = 0 , 1 , .. . ,I;), let y l , . . . ,y nL be independent and identically distributed random variables, each urith a continuous distribution function F,. Suppose that the zero population (i = 0) is the zero-dose control and the other k populations cor~espond to increasing dose treatments. Furthermore, assume that the k + l samples are independent of each other. In this paper, specifically, we consider estimation of the NED, which is the smallest i so that the response in the ith population is stochastically larger than that in the control, namely, F, < Fo,i = 1 , 2 , .. . , k, when the dose-response relationship is either monotonic (ordered; Fo > Fl > . . . > Fk)or nonmonotonic with a down turn (umbrella patterned;
As noted in Tamhane et al. (1996) , the family of null hypotheses H = {Ho,), where Hot: (Fo= Fl = . . . = FtP1= F,) for i = 1 , 2 , .. . , k, is closed under intersection in the sense that Hoz E H and Hod E H imply Hal I -Hod E H. Hence, a level-a closed procedure that includes separate level-a tests of individual Ho, applied in a step-down manner can be employed in finding the NED. kloreover, the closed testing scheme strongly controls the familywise error rate (FWE), which is the probability that at least one true Hot is rejected. Therefore, we consider using the Mann-Whitney statistic incorpo--rated into the step-down closed testing scheme to estimate the VlED.
The two-sample hIann-Whitney statistic comparing the ith dose group with the combined groups of all the lower dose levels (including the control) is (~, ) with AT, + 1 -
, where g is the number of tied groups and t j is the size of tied group j . Moreover, the results in Terpstra (1952) and the projection theorem (cf., Randles and Wolfe, 1979) imply that, under the null hypothesis HOk, TT, T i , . . . ,T i are asymptotically independent and identically distributed (i.i.d.) standard normal. We describe the step-down closed testing scheme proposed by Tamhane et al. (1996) 3. An Example Consider the data set in Table 1 analyzed in Chen and Wolfe (1993) , which contains five dose levels and a zero-dose control. There are three observations in each group. The observations are numbers of visible revertant colonies observed on plates containing Salmonella bacteria of strain TA98 and exposed to different doses of Acid Red 114. The hIann-Whitney statistics, their corresponding means and ties-adjusted variances, and the modified Mann-Whitney statistics are obtained in the following: Tl = 7, T2 = 18, T3 = 27,T4 = 16, T5 = 2,p(T1) = 4.5,p(Tz) = 9,p(T3) = 1 3 . 5 , p ( T~) = 18,p(Ts) = 22.5, a 2 (~1 ) = 5.10, a 2 (~2 ) = 14.88, u 2 (~3 ) = 29.08, u 2 (~4 ) = 4 7 . 6 6 , 0~(~~) = 70.96,T; = l.ll,T,* = 2.33,Ti = 2.50,TZ = -.29,T: = -2.43. Note that the largest statistic among the five T,*'s is T;, so d(5) = 3. Since, at the level a = .05, T$ = 2.50 > z(.010) = 2.326 (.010 % 1 -(.95)1/5), we go to the second step with k2 = 2. We observe that d(2) = 2 and T$ = 2.33 > z(.025) = 1.96 (.025 = 1 -(.95)ll2), but TT = 1.11 < z(.05) = 1.645. Therefore, we estimate that, at the 5% significant level, the NED is the second dose level. 
Average power
,241
Note that the Chen-Wolfe (Chen and Wolfe, 1993) test with These estimators and the average powers, which are employed an estimation of the umbrella peak at high dose levels con-for assessing the power performances of the four tests over all cludes that, at the 5% significant level, the third dose level is the situations considered in the study, are then presented in the only one more effective than the zero-dose control.
Tables 2 and 3.Note that the configurations with true LIED = 1 involve no type I errors, so the entry of estimated FS4-E 4. M o n t e Carlo S t u d y = .000is omitted for all procedures.
SVe conducted a Monte Carlo study to examine the relative We obse~ve from the simulation results that the FIVES level and pourer performances of the competing tests, includ-of all the four procedures are not significantly higher than ing the one considered in Williams (SVILLI) for a monotonic the nominal level .05since they ale all less than ,054(= dose-response relationship, the one proposed in Chen and .05+ 2[(.05)(.95)/10,000]~/~). In fact, the CW test tends to SVolfe (CLA') for unkdown-peak umbrella pattern treatment be conservative in controlling its FLA'E. effects with a down-turn at high dose levels, the modified
The simulation results indicate that the WILL1 test has Chen-Wolfe peak-known test suggested in Chen (CHEN), excellent power when the treatment effects have a monotonic and the step-down closed procedure (SDT) proposed in this ordering. Likewise, the CHEN test provides excellent pourer paper for identifying the LIED. The study was performed against umbrella pattern treatment effects when the peak is for comparing k = 3 and 5 treatments with a control, with correctly chosen. This is not surprising since both tests are no = n l = . . . = nk = n = 5 observations per sample in each designed to estimate the MED for their respective special case, and for a variety of dose-response relationships.
classes of alternatives. The proposed SDT test is, in general, For each of these settings, appropriate normal and exponen-superior to the CW test and outperforms the WILM test for tial deviates were derived by the IMSL routines RNNOR and umbrella treatment effects configurations, especially, with a RNEXP, respectively. The normal distributions under con-sharp downturn. The SDT test is even better than the WILM sideration have the same variance (five) but different means or CHEN test for step-type ordered configurations except for (Qi's), and the exponential distributions have various scale the case where all the treatments are better than the conparameters (0,'s). The designated alternative configurations trol. n'loreover, fol identifying the LIED with the umbrella correspond to values of Oio = 0, -Oo for normal distributions patterned configurations, the pourer of the CHEN test is the and OLo = Qz/Oo for exponential distributions, i . . , k , highest one when k = = 1,2,.
3,while the SDT test has the best which include step-and linear-type ordered treatment effects pourer performance when k = 5.On average, although the and umbrella patterned treatment effects. The FWE and pol%--power of the SDT test is second to the CHEN test for k = 3, ers for the four tests are simulated with 10,000replications. the SDT test is the best one for k = 5. In conclusion, the use of the proposed nonparametric test to On cherche B identifier la dose efficace minimale (DEN) dans identify the N E D is recommended for two reasons. First, the une ktude dose-rkponse oh la DEN est dkfinie comme la dose proposed test involves only the two-sample Mann-Whitney la plus faible produisant UII effet surpassant celui du groupe statistics, which are very easy to compute relative to the es-contr6le soumis & dose zkro. La mkthode ~r o~o s k e une est tablished nonparametric procedures. The proposed test is also prockdure non paramktrique baske sur la statistique de Mannvery easy to implement since the necessary critical values call Whitney (1947) associke B la prockdure de tests, fermke, pas be found from a standard normal table. Second, the proposed a pas descendante, suggkrke par Tamhane et al. (1996) . Un test controls familywise error rate well and has an appreciable exemple numkrique supporte la faisabilitk de cette prockdure pourer performance compared to co~npeting tests. lion paramktrique. Pour conclure, les rksultats comparatifs avec une prockdure de Monte Carlo et une analyse de la puis-ACKNOWLEDGE~IENTS sance statistique dans de petits kchantillons sont prksentks et discutks. This research was supported in part by the National Science Council of Taiwan under the contract NSC87-2121-11-008-006. The author wishes to thank the editor and two referees for their careful reading of the manuscript and their sugges- Chen, Y. I. (1993) . Nonparametric comparisolls of umbrella tions, which lead to an improved presentation of the results.
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